Sales of digestive enzyme preparations and means for restoring intestinal microflora in May – July (for 10 weeks – from May 3 to July 11) in monetary terms increased by 8% compared to the same period last year. Sales of drugs that reduce gastric secretion increased by 13%, and drugs for diarrhea – by 20%, according to a study by DSM Group, prepared for Izvestia.
The most significant growth was observed in mid-June. During this period, sales of enzymes jumped by 19%, diarrhea drugs by 34%, prebiotics by 32%, and gastric secretion suppressants by 24%.
According to doctors, one of the reasons for such dynamics is the spread of the Delta coronavirus strain, emphasized Andrei Pozdnyakov, infectious disease specialist, chief physician of Invitro Siberia. When infected with it, in most cases, a person has diarrhea. At first, this symptom was not even considered a manifestation of COVID-19, the disease was mistaken for a common intestinal infection. The growth in sales of drugs that reduce gastric acidity is also associated with the peculiarities of therapy for coronavirus. Doctors prescribe them when the patient is taking antipyretics, anticoagulants, antibiotics, and anti-inflammatory drugs, including dexamethasone. Together with the latter, doctors must prescribe a drug that reduces the amount of hydrochloric acid in the stomach, noted Andrei Pozdnyakov.
There are more complaints about gastrointestinal problems than in the same period before the pandemic, confirmed the head physician of the Leader-Medicine medical center, virologist Yevgeny Timakov.
Read the full story in the exclusive Izvestia article:
Doesn’t spare the stomach: the Delta coronavirus strain has caused an increase in problems with the gastrointestinal tract